SAN RAMON, Calif., Oct. 9, 2020 /PRNewswire/ -- CooperVision is reporting the latest findings from its landmark MiSight® 1 day clinical study, providing new insights about myopia management and the ...
In the study’s seventh year, participants were transitioned from MiSight ® 1 day to a single vision contact lens to evaluate if treatment gains would be retained. Myopic progression then occurred only ...
The first contact lens designed to slow down the progression of nearsightedness in children will hit the market in March. The U.S. Food and Drug Administration recently approved the MiSight contact ...
SAN RAMON, CALIF., March 10, 2022—A new peer review paper affirms that CooperVision ® MiSight ® 1 day contact lenses provide myopia control for nearly all children. †1 In the longest-running soft ...
To learn more about this innovation and CooperVision's evidence-based myopia management portfolio, visit www.coopervision.co.uk. About CooperVisionCooperVision, a division of CooperCompanies (Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results